COVID-19 vaccine by the end of March through a global vaccine sharing initiative known as COVAX.But as with most things COVID-19, vaccine-related deliveries are mired in the uncertainty of regulatory reviews and potential production delays.The COVAX Facility, co-ordinated by the World Health Organization and Gavi, The Vaccine Alliance, pools funds from wealthier countries to buy vaccines for themselves and for 92 low- and middle-income nations that can’t afford to buy on their own.Canada contributed $440 million to COVAX in September, half of which secured doses for Canada directly, from about nine vaccines that are participating in the program.The other half goes into a pooled fund to buy doses for 20 per cent of the people in 92 low- and.